This suggests that ferroptosis can be effectively attenuated if the intervention occurs before extensive mitochondrial collapse and lipid peroxidation
Vilsbll T, Agers H, Krarup T, Holst JJ
Eli Lilly announced that Retatrutidethe first-in-class GIP, GLP-1, and glucagon triple agonistachieved an average weight loss of 28.7% at 68 weeks in the TRIUMPH-4 Phase 3 trial
FIGURE 1 6 Therapeutic role of AST in AD Numerous studies have explored the roles of AST as a therapeutic option in the AD context, highlighting its ability to ameliorate oxidative stress, improve cognitive function, and decrease disease-related pathophysiological markers (Table 1)
World J Urol
Zhao LH, Yuan QN, Dai AT, He XH, Chen CW, Zhang C, et al